Skip to main content

Table 5 Outcome of the low-risk CBF AML study population by number of treatment courses received

From: Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)

 

Four courses (n = 218)

Five courses (n = 184)

P value

%

95%CI

%

95%CI

CBF (n = 402)

 10-years CIR

30.9

24.7–37.2

27.4

21.2–34.4

0.42

 10-years OS

82.8

75.1–91.2

85.4

80.4–90.8

0.91

inv(16) (n = 164), No. of patients

83

81

 

 10-years CIR

33.9

23.7–44.5

36.1

25.7–46.6

0.67

 10-years OS

92.2

86.5–98.4

88.4

81.5–95.8

0.52

t(8;21) (n = 238), No. of patients

135

103

 

 10-years CIR

29.3

21.7–37.3

19.8

12.6–28.1

0.06

 10-years OS

77

65.8–90.2

83

75.9–90.7

0.73